Circulating miRNAs as a new class of biomedical markers;Les microARN circulants, une nouvelle classe de biomarqueurs pour la médecine

Medecine/Sciences

Volumn 30, Issue 3, 2014, Pages 289-296

  Baulande, Sylvain ^a   Criqui, Audrey ^a   Duthieuw, Mathilde ^a  

^a Parc Scientifique de Luminy   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

ANIMAL; ARTICLE; BLOOD; BODY FLUID; DISEASES; EXTRACELLULAR FLUID; GENETICS; HUMAN; METABOLISM; PARACRINE SIGNALING; PHYSIOLOGY; RNA PROCESSING;

ANIMALS; BIOLOGICAL MARKERS; BODY FLUIDS; DISEASE; EXTRACELLULAR FLUID; HUMANS; MICRORNAS; PARACRINE COMMUNICATION; RNA PROCESSING, POST-TRANSCRIPTIONAL;

EID: 84897505690     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/20143003017     Document Type: Article

References (39)

1. Swarup V, Rajeswari MR. Circulating (cell-free) nucleic acids. A promising, non-invasive tool for early detection of several human diseases. FEBS Lett 2007; 581: 795-799.
2. Gilad S, Meiri E, Yogev Y, et al. Serum microRNAs are promising novel biomarkers. PLoS One 2008; 3: 3148.
3. ENCODE project consortium. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project Nature 2007; 447: 799-816.
4. Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet 2006; 15: R17-R29.
5. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-854.
6. Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993; 75: 855-62.
7. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet 2008; 9: 102-114.
8. Dunoyer P. La bataille du silence: mécanisme et inhibition du RNA silencing au cours des interactions plante/virus. Med Sci (Paris) 2009; 25: 505-512.
9. Sacco L Da, Masotti A. Recent insights and novel bioinformatics tools to understand the role of microRNAs binding to 5' untranslated region. Int J Mol Sci 2012; 14: 480-495.
10. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011; 39: D152-D157.
11. Friedman RC, Farh KK-H, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19: 92-105.
12. Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell 2009; 136: 586-591.
13. Zhang Y, Liu D, Chen X, et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 2010; 39: 133-144.
14. Hergenreider E, Heydt S, Tréguer K, et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 2012; 14: 249-256.
15. Mathivanan S, Fahner CJ, Reid GE, et al. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res 2012; 40: D1241-D1244.
16. Zernecke A, Bidzhekov K, Noels H, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009; 2: ra81.
17. Vickers KC, Palmisano BT, Shoucri BM, et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011; 13: 423-433.
18. Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011; 108: 5003-5008.
19. Turchinovich A, Weiz L, Langheinz A, et al. Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011; 39: 7223-7233.
20. Russo F, Bella S Di, Nigita G, et al. miRandola: extracellular circulating microRNAs database. PLoS One 2012; 7: e47786.
21. Weber JA, Baxter DH, Zhang S, et al. The microRNA spectrum in 12 body fluids. Clin Chem 2010; 56: 1733-1741.
22. Laterza OF, Lim L, Garrett-Engele PW, et al. Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 2009; 55: 1977-1983.
23. Montecalvo A, Larregina AT, Shufesky WJ, et al. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 2012; 119: 756-766.
24. Tréguer K, Heydt S, Hergenreider E. Protection des vaisseaux sanguins contre l'athérosclérose: le rôle des miARN sécrétés par l'endothélium. Med Sci (Paris) 2012; 28: 584-587.
25. Kogure T, Lin W-L, Yan IK, et al. Inter-cellular nanovesicle mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology 2011; 54: 1237-1248.
26. Fabbri M, Paone A, Calore F, et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci USA 2012; 109: E2110-E2116.
27. Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008; 141: 672-675.
28. Guire V De, Robitaille R, Tétreault N, et al. Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: promises and challenges. Clin Biochem 2013; 46: 846-60.
29. Corsten MF, Dennert R, Jochems S, et al. Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 2010; 3: 499-506.
30. Cermelli S, Ruggieri A, Marrero JA, et al. Circulating microRNAs in patients with chronic hepatitis C, non-alcoholic fatty liver disease. PLoS One 2011; 6: e23937.
31. Zampetaki A, Kiechl S, Drozdov I, et al. Plasma microRNA profiling reveals loss of endothelial MiR-126 and other microRNAs in type 2 diabetes. Circ Res 2010; 107: 810-817.
32. Gilad S, Lithwick-Yanai G, Barshack I, et al. Classification of the four main types of lung cancer using a microRNA-based diagnostic assay. J Mol Diagn 2012; 14: 510-517.
33. Chen X, Hu Z, Wang W, et al. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int J Cancer 2012; 130: 1620-1628.
34. Heneghan HM, Miller N, Kerin MJ, Circulating microRNAs: promising breast cancer biomarkers. Breast Cancer Res 2011; 13: 402.
35. Huang Z, Huang D, Ni S, et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010; 127: 118-126.
36. Liu J, Gao J, Du Y, et al. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Int J Cancer 2012; 131: 683-691.
37. Scian M, Maluf D, David K, et al. MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA. Am J Transplant 2011; 11: 2110-2112.
38. Hinault C, Dumortier O, Van Obberghen E. MicroARN et diabète: petites structures, grands effets. Med Sci (Paris) 2013; 29: 785-790.
39. Bournet B, Dufresne M, Selves J, et al. Oncogène Kras et cancer du pancréas: trente ans plus tard. Med Sci (Paris) 2013; 29: 991-997.